±Û·çÄÚ»ç¹Î ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº° ¹× ºÎ¹®º° µ¿Çâ(2023-2030³â)
Glucosamine Market Size, Share & Trends Analysis Report By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, Others), By Application (Supplement, Food & Beverages), By Region, And Segment Forecasts, 2023 - 2030
»óǰÄÚµå
:
1376219
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2023³â 10¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 70 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
±Û·çÄÚ»ç¹Î ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :
Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼¿¡ µû¸£¸é ¼¼°èÀÇ ±Û·çÄÚ»ç¹Î ½ÃÀåÀº 2030³â±îÁö 13¾ï 980¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
2023³âºÎÅÍ 2030³â±îÁö CAGR 5.2%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù. ¼ÒºñÀÚµé »çÀÌ¿¡¼ °ñ°üÀý¿° ¿¹¹æÀ» µ½´Â ¿µ¾ç º¸ÃæÁ¦ Á¦Á¶¿¡¼ ÀÌ Á¦Ç°ÀÇ Àû¿ë ¹üÀ§¸¦ È®´ëÇÏ´Â °ÍÀº ÇâÈÄ 7³â°£ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ƯÈ÷ ¹Ì±¹À» Æ÷ÇÔÇÑ ¼±Áø±¹¿¡¼ ä½ÄÁÖÀÇÀÚÀÎ ¼ÒºñÀÚ ¼ö°¡ Áõ°¡ÇÏ´Â °ÍÀº ¿¹Ãø±â°£ µ¿¾È ¾÷°èÀÇ ¶Ç ´Ù¸¥ ÃËÁø¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¦Ç°Àº ÁÖ·Î »õ¿ì³ª °Ô µîÀÇ °©°¢·ù¿¡¼ Á¦Á¶µÇÁö¸¸, Ä«±æ»ç¿Í ½Ã¾Æ³ëÅØ»ç´Â ¡¸¾Æ½ºÆä¸£±æ·ç½º ¹× ´Ï°Å¡¹±Õ·ù·ÎºÎÅÍ ¼ººÐÀ» ÃßÃâÇÏ´Â °ÍÀ¸·Î, ä½Ä¿ë ±Û·çÄÚ»ç¹ÎÀÇ ÆÄÀÌ¿À´Ï¾Æ°¡ µÇ°í ÀÖ½À´Ï´Ù.
Àα¸ Áõ°¡, °Ç° °ü¸® »ê¾÷ÀÇ ±Þ¼ºÀå, °üÀý°ú »À °Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀº ´Ù¾çÇÑ ½Äǰ ¹× À½·á¿¡¼ ±Û·çÄÚ»ç¹ÎÀÇ »ç¿ëÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ½Äǰ ¹× À½·á Á¦Á¶¿¡ ÀÖ¾î¼ Á¦Ç° »ç¿ë¿¡ °üÇÑ À¯·´ÀÇ ±ÔÁ¦ ƲÀÌ ÁöÁöµÇ°í ÀÖ´Â °Íµµ ÇâÈÄ 7³â°£ÀÇ »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¾îÀ¯ ¹× ¿À¸Þ°¡ 3¸¦ Æ÷ÇÔÇÑ ´ëüǰ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È Á¦Ç° ¼ö¿ä¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù.
±Û·çÄÚ»ç¹Î ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- ±Û·çÄÚ»ç¹Î Ȳ»ê¿° ºÎ¹®Àº 2022³â¿¡ 61.1%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Ȳ»ê ±Û·çÄÚ»ç¹ÎÀº ¿µ¾ç º¸Ãæ±³Àç ¹× ÀǾàǰ¿¡ °¡Àå ³Î¸® »ç¿ëµÇ´Â ±Û·çÄÚ»ç¹Î ÇüÅ Áß ÇϳªÀÔ´Ï´Ù.
- ±Û·çÄÚ»ç¹Î ÇÏÀ̵å·ÎŬ·Î¶óÀÌµå ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 5.2%¶ó´Â, µÎ ¹øÂ°·Î ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±Û·çÄÚ»ç¹Î ÇÏÀ̵å·ÎŬ·Î¶óÀ̵å´Â °üÀý °Ç°À» Áö¿øÇÏ´Â ¿µ¾ç º¸Ãæ±³Àç·Î ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ÈÇÕ¹°ÀÔ´Ï´Ù.
- º¸Ãæ ºÐ¾ß´Â 2022³â¿¡ 79.9%ÀÇ ÃÖ´ë ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ º¸ÃæÁ¦´Â ÁÖ·Î »õ¿ì¿Í °Ô¸¦ Æ÷ÇÔÇÑ °©°¢·ù¿¡¼ »ý»êµÇÁö¸¸ ¾Ë·¹¸£±â »ç·Ê°¡ Áõ°¡ÇÏ°í Æ¯È÷ ¹Ì±¹¿¡¼´Â ä½ÄÁÖÀÇÀÚ°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ Á¦Á¶¾÷ü´Â ±Õ·ù ¹× ±âŸ ½Ä¹°¿ø¿¡¼ Á¦Ç°À» °³¹ßÇϰí ÀÖ½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀåÀ» µ¶Á¡ÇßÀ¸¸ç 2022³â¿¡´Â 47.9%ÀÇ ÃÖ´ë ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ µîÀÇ ±¹°¡¸¦ Æ÷ÇÔÇÏ¿© »ó´çÇÑ Àα¸¿Í È®´ë¸¦ ÀÚ¶ûÇϸç, ÀÌ Áö¿ª Àüü¿¡¼ °Ç°°ú À£ºù¿¡ ´ëÇÑ ÀǽÄÀÌ µ¿½Ã¿¡ ±Þ»ó½ÂÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ±Û·çÄÚ»ç¹Î ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- º¸±Þ ¹× ¼ºÀåÀÇ Àü¸Á ¸ÅÇÎ
- ¹ë·ùüÀÎ ºÐ¼®
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¾÷°èÀÇ ±âȸ¿Í °úÁ¦
- ±Û·çÄÚ»ç¹Î ½ÃÀå ºÐ¼® µµ±¸
- ¾÷°è ºÐ¼®-Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °ø±ÞÀÚ Æ÷Æ®Æú¸®¿À ºÐ¼®
- °ø±Þ¾÷ü ¸ñ·Ï
- Kraljic Matrix
- Á¶´Þ ¸ð¹ü »ç·Ê
- Çù»ó Àü·«
Á¦5Àå ±Û·çÄÚ»ç¹Î : Á¦Ç°ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- ±Û·çÄÚ»ç¹Î ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
- ±Û·çÄÚ»ç¹Î ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022-2030³â)
- ±Û·çÄÚ»ç¹Î Ȳ»ê¿°
- ±Û·çÄÚ»ç¹Î ¿°»ê¿°
- N-¾Æ¼¼Æ¿±Û·çÄÚ»ç¹Î
- ±âŸ
Á¦6Àå ±Û·çÄÚ»ç¹Î: ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- ±Û·çÄÚ»ç¹Î ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
- ±Û·çÄÚ»ç¹Î ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022-2030³â)
- º¸ÃæÁ¦
- ½Äǰ ¹× À½·á
- ±âŸ
Á¦7Àå ±Û·çÄÚ»ç¹Î ½ÃÀå : Áö¿ªÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
- Áö¿ª Àü¸Á
- Áö¿ªº° ±Û·çÄÚ»ç¹Î ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
- ºÏ¹Ì
- ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß³²¹Ì
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ ¹× ¿µÇ⠺м®
- ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
- Koyo Chemical Industry Co., Ltd
- Laboratoires Expanscience
- Nutramax Laboratories Consumer Care, Inc.
- Amway
- CELLMARK AB.
- Alfa Chemical Group
- Cargill, Incorporated
- Dalian Lijian Bio-Technology Development Co. Ltd
- SimplySupplements
AJY
¿µ¹® ¸ñÂ÷
Glucosamine Market Growth & Trends:
The global glucosamine market is expected to reach USD 1309.8 million by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 5.2% from 2023 to 2030. The growing application scope of the product in the manufacturing of nutritional supplements, which aid in the prevention of osteoarthritis among consumers is expected to fuel demand over the next seven years.
An increasing number of vegan consumers particularly in developed countries including the U.S. is expected to be another driver for the industry over the forecast period. The product is primarily manufactured from crustaceans including shrimp and crab; however, Cargill and Cyanotech have pioneered vegetarian glucosamine by extracting the ingredient from 'aspergillus niger' fungi.
The increasing population, rapidly growing healthcare industry, and consumer awareness regarding joint and bone health is expected to fuel the use of glucosamine in various food & beverage products. In addition, supporting regulatory framework in Europe regarding product use in the manufacturing of food & beverages is expected to propel industry growth over the next seven years. However, an increasing number of substitutes including fish oil and omega-3 may challenge product demand over the forecast period.
Glucosamine Market Report Highlights:
- The glucosamine sulfate segment accounted for the largest revenue share of 61.1% in 2022. Glucosamine sulfate has been one of the most widely used forms of glucosamine in dietary supplements and pharmaceuticals
- The glucosamine hydrochloride segment is expected to grow at the second-fastest CAGR of 5.2% over the forecast period. Glucosamine hydrochloride is a compound commonly used as a dietary supplement to support joint health
- The supplement segment held the largest revenue share of 79.9% in 2022. These supplements are mainly manufactured from crustaceans including shrimp and crabs, however, increasing instances of allergy and a rising number of vegans, particularly in the U.S., have led manufacturers to develop the product from fungi and other plant sources
- Asia Pacific dominated the market and accounted for the largest revenue share of 47.9% in 2022. The Asia Pacific region, encompassing countries like China, Japan, India, and Australia, boasts a substantial and expanding population, with a simultaneous surge in health and wellness awareness across the area
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Glucosamine Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market restraint analysis
- 3.5.3. Industry opportunities & challenges
- 3.6. Glucosamines Market Analysis Tools
- 3.6.1. Industry Analysis - Porter's
- 3.6.1.1. Supplier power
- 3.6.1.2. Buyer power
- 3.6.1.3. Substitution threat
- 3.6.1.4. Threat of new entrant
- 3.6.1.5. Competitive rivalry
- 3.6.2. PESTEL Analysis
- 3.6.2.1. Political landscape
- 3.6.2.2. Technological landscape
- 3.6.2.3. Economic landscape
- 3.6.2.4. Social landscape
- 3.6.2.5. Environmental landscape
- 3.6.2.6. Legal landscape
Chapter 4. Supplier Portfolio Analysis
- 4.1. List of Suppliers
- 4.2. Kraljic Matrix
- 4.3. Sourcing Best Practices
- 4.4. Negotiation Strategies
Chapter 5. Glucosamine: Product Estimates & Trend Analysis
- 5.1. Glucosamine Market: Key Takeaways
- 5.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Glucosamine Sulfate
- 5.3.1. Glucosamine sulfate market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
- 5.4. Glucosamine Hydrochloride
- 5.4.1. Glucosamine hydrochloride market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
- 5.5. N-acetyl glucosamine
- 5.5.1. N-acetyl glucosamine market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
- 5.6. Others
- 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
Chapter 6. Glucosamine: Application Estimates & Trend Analysis
- 6.1. Glucosamine Market: Key Takeaways
- 6.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Supplement
- 6.3.1. Supplement market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
- 6.4. Food and Beverage
- 6.4.1. Food and beverage market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
- 6.5. Others
- 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
Chapter 7. Glucosamine Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Glucosamine Market by Region: Key Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. Germany
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. UK
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Central & South America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. Koyo Chemical Industry Co., Ltd
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Laboratoires Expanscience
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Nutramax Laboratories Consumer Care, Inc.
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Amway
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. CELLMARK AB.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Alfa Chemical Group
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Cargill, Incorporated
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Dalian Lijian Bio-Technology Development Co. Ltd
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. SimplySupplements
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
°ü·ÃÀÚ·á